GSD4; glycogenosis type 4; glycogen storage disease type IV, glycogenosis type IV, GSD IV, glycogen branching enzyme deficiency, GBE1 deficiency, Andersen disease, Brancher deficiency, amylopectinosis, familial cirrhosis with deposition of abnormal glycogen, GSD4
Home > Keywords > Physiopathological pathways > Metabolic disease
Metabolic disease
Metabolic pathway
Articles
-
glycogen storage disease type 4
25 April 2004 -
multiple sulfatase deficiency
26 November 2007MSD, mucosulfatidosis, juvenile sulfatidosis Austin type
-
Byler disease
4 June 2003PFIC-1
-
progressive familial intrahepatic cholestasis type 2
4 June 2003PFIC-2
-
Krabbe disease
4 June 2006globoid cell leukodystrophy, GLD, GCL’ globoid cell leukoencephalopathy, galactosylceramide beta-galactosidase deficiency, galactocerebrosidase deficiency, GALC deficiency
-
X-linked dominant chondrodysplasia punctata type 2
30 May 2007CDPX2, Conradi-Hunnermann syndrome, Happle syndrome
-
fucosidosis
29 July 2008Definition: Fucosidosis is an autosomal recessive lysosomal storage disease caused by defective alpha-L-fucosidase with accumulation of fucose in the tissues.
Different phenotypes include clinical features such as neurologic deterioration, growth retardation, visceromegaly, and seizures in a severe early form; coarse facial features, angiokeratoma corporis diffusum, spasticity and delayed psychomotor development in a longer surviving form; and an unusual spondylometaphyseoepiphyseal (...) -
Bartter syndrome
18 March 2005Types
Bartter syndrome type 1 (MIM.601678): loss-of-function mutations in the butmetanide-sensitive sodium-potassium-chloride cotransporter-2 gene (SLC12A1) (MIM.600839)
Bartter syndrome type 2 (MIM.241200): loss-of-function mutation in the potassium channel ROMK1 gene (KCNJ1) (MIM.600359)
Bartter syndrome type 3 (classic Bartter syndrome) (MIM.607364): mutation in the kidney chloride channel B gene (CLCNKB) (MIM.602023)
Bartter syndrome type 4 (infantile Bartter syndrome with (...) -
CHILD syndrome
12 December 2006CHILD syndrome associates congenital hemidysplasia with ichthyosiform nevus and limb defects (MIM.308050). It is an X-linked dominant trait with lethality for male embryos.
A symmetric distribution of this nevus can exceptionally be seen in patients with CHILD syndrome.
The disorder is caused by mutations in NSDHL (MIM.300275), a gene playing an important role in the cholesterol biosynthetic pathway.
CHILD syndrome is due to loss of function of an enzyme involved in cholesterol (...) -
carnitine palmitoyltransferase deficiency type 2
18 March 2005CPT2
0 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | ... | 110